Alicaforsen, an antisense inhibitor of ICAM‐1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series-Reference-Cited by-同舟云学术

Alicaforsen, an antisense inhibitor of ICAM‐1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series

Published:2016-02 Issue:1 Volume:4 Page:97-104
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Greuter Thomas¹,Biedermann Luc¹,Rogler Gerhard¹,Sauter Bernhard²,Seibold Frank³

Affiliation:

1. Division of Gastroenterology and HepatologyUniversity Hospital ZurichZurichSwitzerland

2. Gastrozentrum HirslandenHirslanden Private Clinic GroupZurichSwitzerland

3. Division of Gastroenterology and HepatologyTiefenauspital BernBernSwitzerland

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640615593681

Reference23 articles.

1. T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects

2. Medical management of Crohn's disease

3. Leukocyte adhesion molecules in animal models of inflammatory bowel disease

4. Induction by IL‐1 and interferon‐gamma: Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM‐1);Dustin ML;J Immunol,1986

5. Sequential observation of micrometastasis formation by bacterial lacZ gene-tagged Lewis lung carcinoma cells

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications;Cell Biochemistry and Function;2024-05-12

2. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

3. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009;Zeitschrift für Gastroenterologie;2023-08

4. Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies;Cells;2023-07-27

5. Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs;Expert Review of Anti-infective Therapy;2022-03-03